Loading clinical trials...
Loading clinical trials...
The purpose of this summary is to evaluate the efficacy and safety of R89674 0.025% ophthalmic solution compared with placebo or an active control in subjects with seasonal allergic conjunctivitis
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Vistakon Pharmaceuticals
NCT06686472 · Allergic Conjunctivitis
NCT05839938 · Allergic Conjunctivitis
NCT05186025 · Allergic Rhinitis Due to Pollen, Allergic Conjunctivitis, and more
NCT01471184 · Allergic Rhinitis, Allergic Conjunctivitis
NCT06602726 · Allergic Conjunctivitis
Louisville, Kentucky
North Andover, Massachusetts
Creve Coeur, Missouri
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions